Giant Cell Arteritis
📧 Sign up to get email alerts when something new happens for Giant Cell Arteritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Cardiac Involvement in Patients With Giant Cell Arteritis
This clinical trial update summarizes completed findings on cardiac involvement in patients with Giant cell arteritis (GCA).
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis [Phase 2]
A Phase 2 study evaluating guselkumab for new-onset or relapsing giant cell arteritis has been terminated, with results posted on 2025-07-01…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement [Phase 3]
Phase 3 clinical trial evaluating tocilizumab with steroids for giant cell arteritis with cerebrovascular involvement; the study status is c…
-
CLINICAL_TRIALS research · 2025-06-20Clinical Trial Update: Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
A clinical trial is evaluating a fast-track diagnostic pathway for Giant Cell Arteritis. It is currently recruiting at Groupe Hospitalier de…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis [Phase 2]
This update reports results from a Phase 2 trial of a biologic therapy for refractory primary non-ANCA associated vasculitis; the study was …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients
Completed clinical trial assessing ultra-short glucocorticoid therapy in combination with tocilizumab for giant cell arteritis. The update c…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Bosentan in the Treatment of Giant Cell Arteritis [Phase 2]
A Phase 2 clinical trial is evaluating bosentan for Giant Cell Arteritis; the study status is not yet recruiting.
-
FDA approval · 2025-05-12FDA Approved: TYENNE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for TYENNE (tocilizumab-azg) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AYLo - AutoimmunitY and Loss of y
Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
A University of Bonn clinical trial is currently recruiting to assess a biomarker in patients with giant cell arteritis and polymyalgia rheu…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
This entry describes the Armenian nationwide registry of systemic autoimmune and autoinflammatory diseases, which is currently recruiting pa…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Giant Cell Arteritis - Optimization of Diagnostics
A completed clinical trial evaluating methods to optimize diagnostics for Giant Cell Arteritis.
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
This study investigates predictive factors for treatment response in patients with newly diagnosed polymyalgia rheumatica and giant cell art…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
The study aims to characterize clinical and immunogenetic features of Giant Cell Arteritis and Polymyalgia Rheumatica. It is currently recru…
-
FDA approval · 2025-03-13FDA Approved: TYENNE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for TYENNE (tocilizumab-AAZG) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of upadacitinib for giant cell arteritis has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone [Phase 3]
Phase 3 trial evaluating tocilizumab with an 8-week prednisone taper versus 26 weeks of prednisone in giant cell arteritis; trial not yet re…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis [Phase 2]
A Phase 2 trial is evaluating 18F-AzaFol as a diagnostic tool for giant cell arteritis (a form of large vessel vasculitis) and is currently …
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
This clinical trial update describes a study aiming to predict diverse glucocorticoid toxicity outcomes across inflammatory rheumatic diseas…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: TocILizumab in aorTitis in GCA (TILT)
Clinical trial update for the TILT study evaluating tocilizumab for aortitis in giant cell arteritis (GCA); the trial is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Validation of a Diagnostic Algorithm of Giant Cell Arteritis [NA]
This clinical trial update reports the validation of a diagnostic algorithm for giant cell arteritis. The study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis [Phase 2]
Clinical trial update indicating completion of a Phase 2 study evaluating ustekinumab for relapse of refractory giant cell arteritis.
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)
An update on a completed study evaluating temporal artery biopsy histopathology after dynamic full-field optical coherence tomography (DOCTA…